Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.18 USD | +0.31% | -4.01% | +49.58% |
Mar. 21 | Adverum Biotechnologies Files $200 Million Mixed Shelf | MT |
Mar. 19 | RBC Cuts Price Target on Adverum Biotechnologies to $2 From $3, Keeps Sector Perform, Speculative Risk | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.58% | 231M | |
-3.21% | 102B | |
+1.73% | 96.07B | |
-1.80% | 21.66B | |
-17.87% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.00% | 13.79B | |
-0.65% | 13.33B | |
+19.71% | 10.94B |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.
- Adverum Biotechnologies Gets FDA Orphan Drug Designation for Potential Treatment of Blue Cone Monochromacy